Prostate Assessment With Restriction Spectrum Imaging (RSI) MRI

Description

This single-center study will enroll 40 male participants to complete 2 diffusion magnetic resonance images within 30 days of each other.

Conditions

Prostate Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

This single-center study will enroll 40 male participants to complete 2 diffusion magnetic resonance images within 30 days of each other.

Quantitative Diffusion MRI for Prostate Cancer Detection and Monitoring

Prostate Assessment With Restriction Spectrum Imaging (RSI) MRI

Condition
Prostate Cancer
Intervention / Treatment

-

Contacts and Locations

La Jolla

UCSD Moores Cancer Center, La Jolla, California, United States, 92093

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Male, aged ≥18 years, with histologically confirmed adenocarcinoma of the prostate
  • * Has already undergone prostate MRI and/or scheduled to undergo clinically indicated radical prostatectomy (to permit whole-mount histopathology correlation).
  • * Intended treatment and follow-up according to standard of care for prostate cancer
  • * In good general health as evidenced by medical history and ECOG performance status 0-2
  • * Provision of signed and dated informed consent form
  • * Stated willingness to comply with all study procedures and availability for the duration of the study
  • * Prior treatment for prostate cancer (cryotherapy, high frequency focused ultrasound, prostatectomy)
  • * Hip prosthesis
  • * Contraindication to MRI, per institutional requirements
  • * Patient has a history or current evidence of any condition, therapy, or laboratory abnormality that might confound the results of the trial, interfere with the subject's participation for the full duration of the trial, or is not in the best interest of the subject to participate, in the opinion of the treating investigator.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

MALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of California, San Diego,

Tyler Seibert, MD, PhD, PRINCIPAL_INVESTIGATOR, University of California, San Diego

Study Record Dates

2026-11-01